The role of TLR3 in boosting IFN-β levels is particularly relevant, as IFN-β not only aids in viral clearance but also supports an immune-permissive tumor environment by increasing antigen presentation and stimulating CD8+ T cell responses, which are essential for effective chemotherapy. This evidence concerns the gene CD8A and neoplasm.